The clinical updates which now follow the editorials in The Lancet provide very useful summaries of current knowledge: here is a concise Australian account of stroke management. […]
Lancet 21 Apr 2007 Vol 369

The clinical updates which now follow the editorials in The Lancet provide very useful summaries of current knowledge: here is a concise Australian account of stroke management. […]
A big group of Canadians make a valiant attempt to determine which inhalers really benefit patients with chronic obstructive airways disease. The idea was to start with tiotropium and randomise to salmeterol or salmeterol-fluticasone or placebo. […]
The fritillaries are a wonderful group of bulbous plants, mostly of very discreet charm, quite unlike their blowsy cousins, the tulips. […]
Domhnall MacAuley attending the BMJ/IHI 12th International Forum on Quality and Safety in Health Care, Barcelona April 2007 Airports at 5am on a working day don’t have the same excitement as holiday travel. Suits, briefcases and determined frowns keeping the economy in the air. Nothing like the indignity of putting your toiletries in a clear […]
There has been an outcry at the news that one briefing paper to the MTAS review group suggests doctors who can’t find a job in the UK should consider working for Voluntary Service Overseas (VSO) instead. The BMA says the government’s failures in workforce planning have created this mess. […]
Health secretary Patricia Hewitt has today issued an apology to those caught up in the Medical Training Application Service (MTAS) crisis, acknowledging that it had been a time of ‘great distress’ to them. And she announced another review, this time of the whole of the Modernising Medical Careers policy, rather than just of MTAS. It […]
When I said last week that the true scientist rejoices when her/his hypothesis is refuted, I wasn’t trying to restate Popperian orthodoxy but making the point that those who wish to see knowledge expand shouldn’t care whether it does so by proving them right or wrong – the main thing is that they’ve helped in […]
A big prospective North American trial – COURAGE – confirms the message of the BMJ a fortnight ago: for chronic stable angina, percutaneous coronary intervention offers no advantage over optimal medical therapy. […]
786 Several years ago, Philip Poole-Wilson issued a warning that too many cardiovascular trials use composite end-points and that this can seriously distort their conclusions. […]
Another very promising new drug for HIV has arrived – the HIV-1 integrase inhibitor raltegravir. It produced good results in this phase II trial in multi-drug resistant patients and “the safety profile of raltegravir is comparable with that of placebo at all doses studied. […]